(Q34703693)

4 August 2017

1 reference

title

Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons (English)

1 reference

4 August 2017

1 reference

Quinn M

1

1 reference

PubMed ID

12081758

4 August 2017

Babb P

series ordinal

2

1 reference

4 August 2017

1 July 2002

1 reference

4 August 2017

1 reference

4 August 2017

90

1 reference

4 August 2017

2

1 reference

4 August 2017

162-173

1 reference

Estimates of the worldwide incidence of 25 major cancers in 1990.

4 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Cancer burden in the year 2000. The global picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Risk factors for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

The epidemiology of prostatic cancer. Geographical distribution and time-trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Alcohol consumption and risk of prostate cancer: The Harvard Alumni Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Sexual factors and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Localised prostatic cancer: management and detection issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Results of conservative management of clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Population-based study of long-term survival in patients with clinically localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

The role of increasing detection in the rising incidence of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Changing trends in prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Comparison of trends in prostate-cancer mortality in England and Wales and the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Striking increase in incidence of prostate cancer in men aged < 60 years without improvement in prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Prostate cancer in Denmark: a 50-year population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Trends in incidence of testicular cancer and prostate cancer in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Increased risk of fatal prostate cancer may explain the rise in mortality in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Incidence, mortality and survival from prostate cancer in Vaud and Neuchâtel, Switzerland, 1974-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Analysis of recent trends in prostate cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Impact of screening on prostate cancer rates and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Downward trend in prostate cancer mortality in Quebec and Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Prostate cancer mortality trends in Mexico, 1980-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Trends and characteristics in prostate cancer mortality in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

International trends and patterns of prostate cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Prostate cancer incidence and mortality trends among elderly and adult Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Trends in breast cancer incidence, survival, and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

Relative survival and the estimation of net survival: elements for further discussion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

The decline in cancer mortality in the European Union, 1988–1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2002.2822.X

10.1046/J.1464-410X.2002.2822.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12081758